BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10878813)

  • 1. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells.
    Herreman A; Serneels L; Annaert W; Collen D; Schoonjans L; De Strooper B
    Nat Cell Biol; 2000 Jul; 2(7):461-2. PubMed ID: 10878813
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease. Closing in on gamma-secretase.
    De Strooper B
    Nature; 2000 Jun; 405(6787):627, 629. PubMed ID: 10864307
    [No Abstract]   [Full Text] [Related]  

  • 3. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1.
    Zhang Z; Nadeau P; Song W; Donoviel D; Yuan M; Bernstein A; Yankner BA
    Nat Cell Biol; 2000 Jul; 2(7):463-5. PubMed ID: 10878814
    [No Abstract]   [Full Text] [Related]  

  • 4. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
    Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
    J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
    Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
    J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
    Iwatsubo T
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presenilin-1 mutations in Alzheimer's disease.
    Russo C; Schettini G; Saido TC; Hulette C; Lippa C; Lannfelt L; Ghetti B; Gambetti P; Tabaton M; Teller JK
    Nature; 2000 Jun; 405(6786):531-2. PubMed ID: 10850703
    [No Abstract]   [Full Text] [Related]  

  • 10. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.
    Selkoe DJ
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11039-41. PubMed ID: 11572965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein.
    Laudon H; Mathews PM; Karlström H; Bergman A; Farmery MR; Nixon RA; Winblad B; Gandy SE; Lendahl U; Lundkvist J; Näslund J
    J Neurochem; 2004 Apr; 89(1):44-53. PubMed ID: 15030388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
    Xia W; Ostaszewski BL; Kimberly WT; Rahmati T; Moore CL; Wolfe MS; Selkoe DJ
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly and activation of the gamma-secretase complex: roles of presenilin cofactors.
    Iwatsubo T
    Mol Psychiatry; 2004 Jan; 9(1):8-10. PubMed ID: 14581930
    [No Abstract]   [Full Text] [Related]  

  • 14. Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gamma-secretase blockage.
    Qyang Y; Chambers SM; Wang P; Xia X; Chen X; Goodell MA; Zheng H
    Biochemistry; 2004 May; 43(18):5352-9. PubMed ID: 15122901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
    Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
    Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The complex enzymic process yielding beta-amyloid protein in Alzheimer's disease].
    Sela B
    Harefuah; 2000 Jul; 139(1-2):42-7. PubMed ID: 10979452
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
    Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
    Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
    Iwatsubo T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease. A technical KO of amyloid-beta peptide.
    Haass C; Selkoe DJ
    Nature; 1998 Jan; 391(6665):339-40. PubMed ID: 9450743
    [No Abstract]   [Full Text] [Related]  

  • 20. Intramembrane proteolysis by presenilins.
    Steiner H; Haass C
    Nat Rev Mol Cell Biol; 2000 Dec; 1(3):217-24. PubMed ID: 11252897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.